This research proposes an innovative data model to determine the landscape of emerging technologies.
It is based on a competitive technology intelligence methodology that incorporates the assessment of scientific publications and patent analysis production, and is further supported by experts’ feedback. It enables the definition of the growth rate of scientific and technological output in terms of the top countries, institutions and journals producing knowledge within the field as well as the identification of main areas of research and development by analyzing the International Patent Classification codes including keyword clusterization and co-occurrence of patent assignees and patent codes.
This model was applied to the evolving domain of 3D bioprinting. Scientific documents from the Scopus and Web of Science databases, along with patents from 27 authorities and 140 countries, were retrieved. In total, 4782 scientific publications and 706 patents were identified from 2000 to mid-2016.
The number of scientific documents published and patents in the last five years showed an annual average growth of 20% and 40%, respectively. Results indicate that the most prolific nations and institutions publishing on 3D bioprinting are the USA and China, including the Massachusetts Institute of Technology (USA), Nanyang Technological University (Singapore) and Tsinghua University (China), respectively. Biomaterials and Biofabrication are the predominant journals.
The most prolific patenting countries are China and the USA; while Organovo Holdings Inc. (USA) and Tsinghua University (China) are the institutions leading. International Patent Classification codes reveal that most 3D bioprinting inventions intended for medical purposes apply porous or cellular materials or biologically active materials.
FeLV | AG20-0281-Z |
|||
AG20-0281-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 516 |
Description: FeLV ; AG20-0281-Z ; Immunology Consultants Laboratory Species Reactivity: p27 Format: Unconjugated AP Product Type: Protein Standard Source: E.coli |
FIPV N | AG20-0344-Z |
|||
AG20-0344-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 516 |
Description: FIPV N ; AG20-0344-Z ; Immunology Consultants Laboratory Species Reactivity: FIPVN Format: Unconjugated AP Product Type: Protein Standard Source: E.coli |
Purified CHO MMP-19 Protein | AG65-0424-01-Z |
|||
AG65-0424-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 894 |
Description: Purified CHO MMP-19 Protein ; AG65-0424-01-Z ; Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
AG-14361 |
|||
27602-1 | BPS Bioscience | 5 mg | EUR 205 |
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks. |
AG-14361 |
|||
27602-2 | BPS Bioscience | 10 mg | EUR 360 |
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks. |
AG-14361 |
|||
27602-3 | BPS Bioscience | 50 mg | EUR 825 |
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks. |
AG14361 |
|||
401020 | MedKoo Biosciences | 1.0mg | EUR 215 |
AG14361 |
|||
E1KS2178 | EnoGene | 10mg | EUR 1118.4 |
AG-14361 |
|||
B2175-25 | Biovision | each | EUR 907.2 |
AG-14361 |
|||
A4158-10 | ApexBio | 10 mg | EUR 184 |
Description: Potent PARP1 inhibitor |
AG-14361 |
|||
A4158-100 | ApexBio | 100 mg | EUR 792 |
Description: Potent PARP1 inhibitor |
AG-14361 |
|||
A4158-5 | ApexBio | 5 mg | EUR 96 |
Description: Potent PARP1 inhibitor |
AG-14361 |
|||
A4158-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 123 |
Description: Potent PARP1 inhibitor |
AG-14361 |
|||
A4158-50 | ApexBio | 50 mg | EUR 544 |
Description: Potent PARP1 inhibitor |
AG-17724 |
|||
564489 | MedKoo Biosciences | 5.0mg | EUR 310 |
AG-13958 |
|||
GW6755-1 | Glentham Life Sciences | 1 | EUR 450.8 |
AG-13958 |
|||
GW6755-10 | Glentham Life Sciences | 10 | EUR 1291.7 |
AG-13958 |
|||
GW6755-5 | Glentham Life Sciences | 5 | EUR 855.4 |
AG14361 |
|||
HY-12032 | MedChemExpress | 50mg | EUR 1341.6 |
AG-13958 |
|||
HY-15492 | MedChemExpress | 100mg | EUR 5156.4 |
AG-13958 |
|||
T7493-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG-13958 |
AG-13958 |
|||
T7493-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG-13958 |
AG-13958 |
|||
T7493-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG-13958 |
AG-13958 |
|||
T7493-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG-13958 |
AG-13958 |
|||
T7493-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG-13958 |
AG14361 |
|||
T6339-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG14361 |
AG14361 |
|||
T6339-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG14361 |
AG14361 |
|||
T6339-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG14361 |
AG14361 |
|||
T6339-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG14361 |
AG14361 |
|||
T6339-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG14361 |
Purified Annexin A5 Protein | AG65-0425-01-Z |
|||
AG65-0425-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 364 |
Description: Purified Annexin A5 Protein ; AG65-0425-01-Z ; Immunology Consultants Laboratory Host: CHO Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Axitinib (AG-013736) |
|||
1581-25 | Biovision | each | EUR 464.4 |
Axitinib (AG-013736) |
|||
1581-5 | Biovision | each | EUR 229.2 |
AG-014699 phosphate |
|||
2890-1 | Biovision | each | EUR 157.2 |
AG-014699 phosphate |
|||
2890-5 | Biovision | each | EUR 444 |
Purified CHO Legumain Protein | AG65-0423-01-Z |
|||
AG65-0423-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 894 |
Description: Purified CHO Legumain Protein ; AG65-0423-01-Z ; Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
Purified CHO Nidogen-1 Protein | AG65-0426-01-Z |
|||
AG65-0426-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 894 |
Description: Purified CHO Nidogen-1 Protein ; AG65-0426-01-Z ; Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
AG-014699(PF-01367338) |
|||
E1KS1098 | EnoGene | 5mg | EUR 422.4 |
Purified GFP | AG45-0205-Z |
|||
AG45-0205-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 348 |
Description: Purified GFP ; AG45-0205-Z ; Immunology Consultants Laboratory Species Reactivity: GFP Format: Unconjugated AP Product Type: Protein Standard Source: E.coli |
Purified CHO Clusterin Protein | AG65-0075-01-Z |
|||
AG65-0075-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 894 |
Description: Purified CHO Clusterin Protein ; AG65-0075-01-Z ; Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
AG28262 free base |
|||
T29706-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG28262 free base |
AG28262 free base |
|||
T29706-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG28262 free base |
AG28262 free base |
|||
T29706-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG28262 free base |
AG28262 free base |
|||
T29706-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG28262 free base |
AG28262 free base |
|||
T29706-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG28262 free base |
Purified Beta 2-Microglobulin Protein | AG65-0041-01-Z |
|||
AG65-0041-01-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 894 |
Description: Purified Beta 2-Microglobulin Protein ; AG65-0041-01-Z ; Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
Purified CHO GSTp Protein | AG65-0337 |
|||
AG65-0337 | Immunology Consultants Laboratory | 1.0 mg | EUR 6110 |
Description: Purified CHO GSTp Protein ; AG65-0337 ; Immunology Consultants Laboratory Species Reactivity: CHO (S-cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
AG1296 |
|||
20-abx076758 | Abbexa |
|
|
AG-7404 |
|||
530656 | MedKoo Biosciences | 1.0mg | EUR 150 |
AG-1478 |
|||
A8357-25 | ApexBio | 25 mg | EUR 120 |
Description: EGFR inhibitor,potent and selective |
AG-1478 |
|||
A8357-5 | ApexBio | 5 mg | EUR 40 |
Description: EGFR inhibitor,potent and selective |
AG-1478 |
|||
A8357-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 40 |
Description: EGFR inhibitor,potent and selective |
AG-1478 |
|||
A8357-50 | ApexBio | 50 mg | EUR 200 |
Description: EGFR inhibitor,potent and selective |
AG-1296 |
|||
2376-5 | Biovision | each | EUR 235.2 |
AG-1478 |
|||
401019 | MedKoo Biosciences | 100.0mg | EUR 450 |
AG1296 |
|||
406209 | MedKoo Biosciences | 25.0mg | EUR 250 |
AG1295 |
|||
406210 | MedKoo Biosciences | 10.0mg | EUR 330 |
AG-1024 |
|||
406233 | MedKoo Biosciences | 5.0mg | EUR 240 |
AG-1557 |
|||
407453 | MedKoo Biosciences | 25.0mg | Ask for price |
AG-1557 |
|||
C5417-10 | ApexBio | 10 mg | EUR 123 |
Description: inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase |
AG-1557 |
|||
C5417-25 | ApexBio | 25 mg | EUR 295 |
Description: inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase |
AG-1557 |
|||
C5417-5 | ApexBio | 5 mg | EUR 66 |
Description: inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase |
AG-1557 |
|||
C5417-50 | ApexBio | 50 mg | EUR 523 |
Description: inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase |
AG-1295 |
|||
C5465-10 | ApexBio | 10 mg | EUR 174 |
Description: potent and selective inhibitor of PDGF receptor kinase |
AG-1295 |
|||
C5465-25 | ApexBio | 25 mg | EUR 366 |
Description: potent and selective inhibitor of PDGF receptor kinase |
AG-1295 |
|||
C5465-5 | ApexBio | 5 mg | EUR 94 |
Description: potent and selective inhibitor of PDGF receptor kinase |
AG-1024 |
|||
A2673-10 | ApexBio | 10 mg | EUR 88 |
Description: Selective IGF-1R inhibitor |
AG-1024 |
|||
A2673-25 | ApexBio | 25 mg | EUR 166 |
Description: Selective IGF-1R inhibitor |
AG-1024 |
|||
A2673-5 | ApexBio | 5 mg | EUR 48 |
Description: Selective IGF-1R inhibitor |
AG-1024 |
|||
A2673-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 55 |
Description: Selective IGF-1R inhibitor |
AG-1295 |
|||
A425200 | Toronto Research Chemicals | 100mg | EUR 356 |
Description: 71897-07-9 |
AG-1478 |
|||
HY-13524 | MedChemExpress | 50mg | EUR 472.8 |
AG1024 |
|||
HY-10253 | MedChemExpress | 10mg | EUR 252 |
AG1296 |
|||
SIH-426-25MG | Stressmarq | 25 mg | EUR 443 |
Description: PDGFR kinase inhibitor |
AG1296 |
|||
SIH-426-5MG | Stressmarq | 5 mg | EUR 107 |
Description: PDGFR kinase inhibitor |
AG1433 |
|||
T23660-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG1433 |
AG1433 |
|||
T23660-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG1433 |
AG1433 |
|||
T23660-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG1433 |
AG1433 |
|||
T23660-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG1433 |
AG1433 |
|||
T23660-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG1433 |
AG1024 |
|||
T2693-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG1024 |
AG1024 |
|||
T2693-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG1024 |
AG1024 |
|||
T2693-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG1024 |
AG1024 |
|||
T2693-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG1024 |
AG1024 |
|||
T2693-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG1024 |
AG-1859 |
|||
T26571-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG-1859 |
AG-1859 |
|||
T26571-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG-1859 |
AG-1859 |
|||
T26571-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG-1859 |
AG-1859 |
|||
T26571-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG-1859 |
AG-1859 |
|||
T26571-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG-1859 |
AG2034 |
|||
T26572-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG2034 |
AG2034 |
|||
T26572-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG2034 |
AG2034 |
|||
T26572-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG2034 |
AG2034 |
|||
T26572-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG2034 |
AG2034 |
|||
T26572-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG2034 |
AG-7404 |
|||
T26574-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG-7404 |
AG-7404 |
|||
T26574-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG-7404 |
AG-7404 |
|||
T26574-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG-7404 |
AG-7404 |
|||
T26574-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG-7404 |
AG-7404 |
|||
T26574-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG-7404 |
AG1557 |
|||
T2034-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG1557 |
AG1557 |
|||
T2034-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG1557 |
AG1557 |
|||
T2034-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG1557 |
AG1557 |
|||
T2034-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG1557 |
AG1557 |
|||
T2034-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG1557 |
AG-1801 |
|||
T29703-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG-1801 |
AG-1801 |
|||
T29703-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG-1801 |
AG-1801 |
|||
T29703-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG-1801 |
AG-1801 |
|||
T29703-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG-1801 |
AG-1801 |
|||
T29703-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG-1801 |
AG-1478 |
|||
T2047-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG-1478 |
AG-1478 |
|||
T2047-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG-1478 |
AG-1478 |
|||
T2047-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG-1478 |
AG-1478 |
|||
T2047-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG-1478 |
AG-1478 |
|||
T2047-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG-1478 |
AG6033 |
|||
T63605-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG6033 |
AG6033 |
|||
T63605-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG6033 |
AG6033 |
|||
T63605-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG6033 |
AG6033 |
|||
T63605-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG6033 |
AG6033 |
|||
T63605-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG6033 |
AG-1296 |
|||
abx076758-100l | Abbexa | 100 µl | EUR 131.25 |
AG-1296 |
|||
abx076758-1ml | Abbexa | 1 ml | Ask for price |
AG-1296 |
|||
abx076758-200l | Abbexa | 200 µl | EUR 362.5 |
AG-1478 |
|||
abx282513-100g | Abbexa | 100 µg | Ask for price |
AG-1478 |
|||
abx282513-20g | Abbexa | 20 µg | EUR 118.75 |
AG-1478 |
|||
abx282513-50g | Abbexa | 50 µg | EUR 237.5 |
Rucaparib (AG-014699,PF-01367338) |
|||
27647-1 | BPS Bioscience | 5 mg | EUR 140 |
Description: Rucaparib, also known as AG-014699 or PF-01367338, is an inhibitor of PARP1 with Ki of 1.4 nM. |
Rucaparib (AG-014699,PF-01367338) |
|||
27647-2 | BPS Bioscience | 10 mg | EUR 195 |
Description: Rucaparib, also known as AG-014699 or PF-01367338, is an inhibitor of PARP1 with Ki of 1.4 nM. |
Rucaparib (AG-014699,PF-01367338) |
|||
27647-3 | BPS Bioscience | 50 mg | EUR 475 |
Description: Rucaparib, also known as AG-014699 or PF-01367338, is an inhibitor of PARP1 with Ki of 1.4 nM. |
Rucaparib (AG-014699,PF-01367338) |
|||
A4156-10 | ApexBio | 10 mg | EUR 104 |
Description: Potent PARP inhibitor |
Rucaparib (AG-014699,PF-01367338) |
|||
A4156-200 | ApexBio | 200 mg | EUR 680 |
Description: Potent PARP inhibitor |
Rucaparib (AG-014699,PF-01367338) |
|||
A4156-5 | ApexBio | 5 mg | EUR 60 |
Description: Potent PARP inhibitor |
Rucaparib (AG-014699,PF-01367338) |
|||
A4156-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 72 |
Description: Potent PARP inhibitor |
Rucaparib (AG-014699,PF-01367338) |
|||
A4156-50 | ApexBio | 50 mg | EUR 280 |
Description: Potent PARP inhibitor |
Rucaparib (AG-014699,PF-01367338) |
|||
A4156-S | ApexBio | Evaluation Sample | EUR 22 |
Description: Potent PARP inhibitor |
Dengue NS1 Protein-Type 1 | AG55-0258-Z |
|||
AG55-0258-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 364 |
Description: Dengue NS1 Protein-Type 1 ; AG55-0258-Z ; Immunology Consultants Laboratory Species Reactivity: NS1 Format: Unconjugated AP Product Type: Protein Standard Source: HEK-293 |
Dengue NS1 Protein-Type 2 | AG55-0259-Z |
|||
AG55-0259-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 364 |
Description: Dengue NS1 Protein-Type 2 ; AG55-0259-Z ; Immunology Consultants Laboratory Species Reactivity: NS1 Format: Unconjugated AP Product Type: Protein Standard Source: HEK-293 |
Dengue NS1 Protein-Type 2 | AG55-0259-Z |
|||
AG55-0260-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 364 |
Description: Dengue NS1 Protein-Type 3 ; AG55-0260-Z ; Immunology Consultants Laboratory Species Reactivity: NS1 Format: Unconjugated AP Product Type: Protein Standard Source: HEK-293 |
Dengue NS1 Protein-Type 4 | AG55-0261-Z |
|||
AG55-0261-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 364 |
Description: Dengue NS1 Protein-Type 4 ; AG55-0261-Z ; Immunology Consultants Laboratory Species Reactivity: NS1 Format: Unconjugated AP Product Type: Protein Standard Source: HEK-293 |
Purified CHO PLBL2 Protein | AG65-0324 |
|||
AG65-0324 | Immunology Consultants Laboratory | 1.0 mg | EUR 6110 |
Description: Purified CHO PLBL2 Protein ; AG65-0324 ; Immunology Consultants Laboratory Species Reactivity: CHO (3E7 cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
Purified CHO GSTp Protein | AG65-0337-Z |
|||
AG65-0337-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 818 |
Description: Purified CHO GSTp Protein ; AG65-0337-Z ; Immunology Consultants Laboratory Species Reactivity: CHO (S-cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
Purified CHO PLBL2 Protein | AG65-0365 |
|||
AG65-0365 | Immunology Consultants Laboratory | 1.0 mg | EUR 6110 |
Description: Purified CHO PLBL2 Protein ; AG65-0365 ; Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
AG1478 HCl |
|||
563014 | MedKoo Biosciences | 10.0mg | EUR 350 |
AG-1517 HCl |
|||
abx076745-100l | Abbexa | 100 µl | EUR 143.75 |
AG-1517 HCl |
|||
abx076745-1ml | Abbexa | 1 ml | Ask for price |
AG-1517 HCl |
|||
abx076745-200l | Abbexa | 200 µl | EUR 387.5 |
Purified CHO PLBL2 Protein | AG65-0324-Z |
|||
AG65-0324-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 818 |
Description: Purified CHO PLBL2 Protein ; AG65-0324-Z ; Immunology Consultants Laboratory Species Reactivity: CHO (3E7 cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
Purified CHO PLBL2 Protein | AG65-0365-Z |
|||
AG65-0365-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 818 |
Description: Purified CHO PLBL2 Protein ; AG65-0365-Z ; Immunology Consultants Laboratory Species Reactivity: CHO (S cell line) Format: Unconjugated AP Product Type: Protein Standard Source: N/A |
Plasmodium falciparum | AG55-0092-Z |
|||
AG55-0092-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 410 |
Description: Plasmodium falciparum ; AG55-0092-Z ; Immunology Consultants Laboratory Species Reactivity: HRP2 Format: Unconjugated AP Product Type: Protein Standard Source: E.coli |
AG-1812 free base |
|||
T29704-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG-1812 free base |
AG-1812 free base |
|||
T29704-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG-1812 free base |
AG-1812 free base |
|||
T29704-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG-1812 free base |
AG-1812 free base |
|||
T29704-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG-1812 free base |
AG-1812 free base |
|||
T29704-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG-1812 free base |
AG-2000 Free Base |
|||
T29705-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AG-2000 Free Base |
AG-2000 Free Base |
|||
T29705-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AG-2000 Free Base |
AG-2000 Free Base |
|||
T29705-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AG-2000 Free Base |
AG-2000 Free Base |
|||
T29705-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AG-2000 Free Base |
AG-2000 Free Base |
|||
T29705-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AG-2000 Free Base |
A630001G21Rik (GFP-tagged) - Mouse RIKEN cDNA A630001G21 gene (A630001G21Rik), (10ug) |
|||
MG213122 | Origene Technologies GmbH | 10 µg | Ask for price |
Knowledge clusters and expert drivers indicate that there is a research focus on tissue engineering including the fabrication of organs, bioinks and new 3D bioprinting systems. Our model offers a guide to researchers to understand the knowledge production of pioneering technologies, in this case 3D bioprinting.